Canada negotiates additional agreement with Moderna for vaccine supply beyond 2021 

Canada negotiates additional agreement with Moderna for vaccine supply beyond 2021 

The Honourable Anita Anand, Minister of Public Services and Procurement, announced that Canada has entered into an agreement with Moderna for additional supply of its COVID-19 vaccine for 2022 and 2023, with an option to extend into 2024.

The agreement guarantees access to 40 million doses, with access to up to 65 million more if all options are exercised. The agreement will allow access to new COVID-19 vaccine adaptations based on the evolution of the epidemiological situation in Canada.

The Government of Canada will continue to follow scientific and expert advice to pursue future access to COVID-19 vaccines.

Quotes

“Our government is continuing to work with leading vaccine developers in order to ensure that Canadians have ongoing access to a diverse portfolio of vaccines. This agreement will help to bridge Canada’s capacity to maintain a reliable and rapidly available supply of vaccines into 2022 and 2023 ahead of Moderna’s Canadian vaccine facility becoming operational.”

The Honourable Anita Anand
Minister of Public Services and Procurement